So it's a really, really complicated issue because the state is thinking about trade-offs, but these drugs also, they're so effective, so it's just a really difficult issue
It's important for the oncology team to know when patients are starting these agents because many of them have gastrointestinal [adverse] effects, which might be confused with an exacerbation of carcinoid syndrome, which is seen in [patients with] neuroendocrine tumors, which might lead to an increase in the therapy for neuroendocrine tumors, which would not be appropriate
The hydrophilicity of DFO also limits its permeability through the cells, including neurons (Kontoghiorghes and Kontoghiorghe, 2016), requiring higher doses that can increase the risk of severe systemic side effects such as cardiomyopathy, hepatic or renal failure, and neurotoxicity (Xu et al., 2024)
Twenty years later, he's still in the ring with inflammation, but now, with an entirely new skin-care collection to help fight it
She has seen no weight loss after three months